Gewinn Vor Steuern Veränderung Datum
Acadia Pharmaceuticals USD 44.6M 4.38M 2025-09
Agios Pharmaceuticals USD -103.43M 8.59M 2025-09
Akebia Therapeutics USD 6.11M 28.92M 2025-03
Alnylam Pharmaceuticals USD 238.97M 274.33M 2025-09
Anika Therapeutics USD -3.87M 32.43M 2025-03
Arrowhead Research USD 28.27M 7.85M 2025-12
AstraZeneca USD 3.24B 117M 2025-09
Bristol-Myers Squibb USD 3.11B 1.34B 2025-09
Eli Lilly USD 7.23B 456M 2025-09
Enanta Pharmaceuticals USD -22.71M 95.08M 2024-12
Esperion Therapeutics USD 67.66M 3.6M 2024-09
Halozyme Therapeutics USD 218.96M 14.02M 2025-09
Heron Therapeutics USD -4.85M 4.39M 2024-09
Insmed USD -368.7M 48.26M 2025-09
J&J USD 4.97B 2.53B 2025-12
Lexicon Pharmaceuticals USD -53.43M 5.03M 2024-06
Ligand Pharmaceuticals USD 141.14M 102M 2025-09
Merck USD 6.74B 22M 2025-09
Minerva Neurosciences USD 22.51M 30.74M 2024-09
Moderna USD -187M 631M 2025-09
Novartis USD 5.17B 637M 2025-09
Pfizer USD 3.33B 290M 2025-09
PTC Therapeutics USD -23.07M 47.98M 2025-09
Puma Biotechnology USD 20.61M 24.76M 2024-09
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Sanofi EUR -1.16B 5.5B 2025-12
Takeda JPY 133.86B 105.69B 2025-12
Teva Pharmaceutical Industries USD 91M 555M 2025-12
Ultragenyx Pharmaceutical USD -179.54M 65.54M 2025-09
Vanda Pharmaceuticals USD -22.92M 16.68M 2024-12
Veracyte USD 18.89M 17.64M 2025-09


Vanda Pharmaceuticals Gewinn Vor Steuern - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.